β¨ Health and Medicines Notices
1826
NEW ZEALAND GAZETTE
No. 79
Dated at Wellington this 25th day of June 1999.
KATHY PHILLIPS, Senior Manager, National Operations.
go4772
Health
Health Reforms (Transitional Provisions) Act 1993
Appointment of Directors of Residual Health Management Unit
Pursuant to section 18(2) of the Health Reforms (Transitional Provisions) Act 1993, and in accordance with clause 3 of the Second Schedule to the Health and Disability Services Act 1993, I re-appoint each of the following persons as a director of the board of the Residual Health Management Unit for the term specified for that person on the conditions specified in the Schedule to this notice.
Pursuant to clause 2(1) of the Second Schedule to the Health and Disability Services Act 1993, I appoint Ian Miller as chairperson of the board of the Residual Health Management Unit, commencing on the 1st day of July 1999 and expiring on the 30th day of June 2000.
| Director | Term of Re-Appointment |
|---|---|
| Ian Miller | 1 July 1999β30 June 2000 |
| Peter Farley | 1 July 1999β30 June 2000 |
Schedule
Compliance with the Management Agreement dated 30 September 1993 between the Minister of Health and the Residual Health Management Unit.
Dated at Wellington this 30th day of June 1999.
HON. WYATT CREECH, Minister of Health.
go4787
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Trade Name: Complete ComfortPlus.
Dosage Form: Contact lens solution.
NZ Sponsor: Allergan New Zealand Limited.
Active Ingredient(s): Hypromellose 1.5 mg/mL.
Poloxamers 0.5 mg/mL.
Polyhexamethylene Biguanide 0.001 mg/mL.
Manufacturer(s): Allergan Pharmaceuticals (Ireland) Limited, Westport, County Mayo, Ireland.
Trade Name: Cycrin.
Dosage Form: Tablet.
NZ Sponsor: Wyeth (NZ) Limited.
Active Ingredient(s): Medroxyprogesterone acetate 2.5 mg.
Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland.
Trade Name: Cycrin.
Dosage Form: Tablet.
NZ Sponsor: Wyeth (NZ) Limited.
Active Ingredient(s): Medroxyprogesterone acetate 5 mg.
Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland.
Trade Name: Cycrin.
Dosage Form: Tablet.
NZ Sponsor: Wyeth (NZ) Limited.
Active Ingredient(s): Medroxyprogesterone acetate 10 mg.
Manufacturer(s): Wyeth Medica Ireland, Newbridge, County Kildare, Ireland.
Trade Name: Nurofen Advance.
Dosage Form: Film coated tablet.
NZ Sponsor: Boots Healthcare New Zealand Limited.
Active Ingredient(s): Ibuprofen lysinate 342 mg equivalent to 200 mg ibuprofen.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1999, No 79
NZLII —
NZ Gazette 1999, No 79
β¨ LLM interpretation of page content
π₯ Appointment of Directors of Residual Health Management Unit
π₯ Health & Social Welfare30 June 1999
Health Reforms (Transitional Provisions) Act 1993, Residual Health Management Unit, Appointments
- Ian Miller, Appointed chairperson and director of the board
- Peter Farley, Re-appointed director of the board
- HON. WYATT CREECH, Minister of Health
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act 1981, New Medicines, Consent to Distribution